Brief: Priveterra Acquisition Announces Authorization To List On NYSE Upon Completion Of Business Combination With Aeon Biopharma
17/07/2023 22:15
July 17 (Reuters) - Priveterra Acquisition Corp
PMGM.O :
* PRIVETERRA ACQUISITION CORP. ANNOUNCES AUTHORIZATION TO
LIST ON
NYSE UPON COMPLETION OF BUSINESS COMBINATION WITH AEON
BIOPHARMA, INC.
Source text for Eikon: ID:nBw30lrdra
Further company coverage: PMGM.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Aeon Biopharma
See all newsBrief: Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions
Brief: Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong
Brief: Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling
Brief: Aeon Biopharma Announces FDA bpd Type 2A Meeting For Abp-450 On November 19
Brief: Aeon Biopharma Announces CEO Transition